Colgate-Palmolive Company $CL Stock Position Lowered by Axxcess Wealth Management LLC

Key Points

• Axxcess Wealth Management cut its Colgate-Palmolive stake by 78.5% in the third quarter, selling 35,187 shares and retaining 9,609 shares valued at about $820,000. Institutional investors and hedge funds collectively own 80.41% of the stock.
• Colgate-Palmolive reported quarterly adjusted earnings of $0.99 per share, beating estimates of $0.95, while revenue reached $5.36 billion and increased 4.9% year over year. The company also declared a quarterly dividend of $0.53, equal to a 2.3% annualized yield.
• Analyst sentiment remains favorable, with a “Moderate Buy” consensus and an average price target of $98, but insider selling and concerns about inflation, tariffs, competition and consumer spending remain risks.

Axxcess Wealth Management LLC trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 78.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,609 shares of the company's stock after selling 35,187 shares during the quarter. Axxcess Wealth Management LLC's holdings in Colgate-Palmolive were worth $820,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in CL. Virginia Estate & Retirement Planning Advisors Inc. raised its position in Colgate-Palmolive by 1,409.1% during the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company's stock worth $28,000 after acquiring an additional 310 shares during the period. Parvin Asset Management LLC purchased a new position in Colgate-Palmolive during the second quarter valued at $32,000. Park Place Capital Corp grew its position in shares of Colgate-Palmolive by 55.5% in the second quarter. Park Place Capital Corp now owns 356 shares of the company's stock valued at $33,000 after purchasing an additional 127 shares during the period. Cherry Tree Wealth Management LLC grew its position in shares of Colgate-Palmolive by 7,840.0% in the second quarter. Cherry Tree Wealth Management LLC now owns 397 shares of the company's stock valued at $36,000 after purchasing an additional 392 shares during the period. Finally, Montgomery Financial Services LLC purchased a new stake in shares of Colgate-Palmolive during the second quarter worth about $36,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Colgate-Palmolive

In related news, COO Panagiotis Tsourapas sold 10,000 shares of the stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer owned 64,901 shares of the company's stock, valued at approximately $5,974,137.05. This trade represents a 13.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director John Cahill sold 4,170 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the transaction, the director owned 28,373 shares in the company, valued at approximately $2,649,187.01. The trade was a 12.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 175,191 shares of company stock valued at $16,110,903. 0.43% of the stock is currently owned by insiders.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $94.10 on Friday. The firm has a 50-day simple moving average of $89.26 and a 200-day simple moving average of $89.35. The stock has a market capitalization of $75.02 billion, a price-to-earnings ratio of 37.34, a price-to-earnings-growth ratio of 4.55 and a beta of 0.33. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, topping analysts' consensus estimates of $0.95 by $0.04. The firm had revenue of $5.36 billion for the quarter, compared to analyst estimates of $5.36 billion. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. Colgate-Palmolive's quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.92 earnings per share. On average, equities analysts predict that Colgate-Palmolive Company will post 3.87 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a $0.53 dividend. The ex-dividend date is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. Colgate-Palmolive's dividend payout ratio is 84.13%.

More Colgate-Palmolive News

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Analysts expect earnings growth, and Zacks says Colgate-Palmolive has a favorable combination of earnings estimates and historical earnings surprises that could support a quarterly beat. Colgate-Palmolive earnings expectations
• Positive Sentiment: Recent coverage has highlighted strong toothpaste performance, while Colgate-Palmolive India reported 12.2% revenue growth, 4.3% profit growth and modest gross-margin expansion. These results may offer some support for the broader brand portfolio, although the Indian subsidiary is not the same entity as the U.S.-listed parent. Colgate-Palmolive India quarterly results
• Neutral Sentiment: Options activity was elevated, with investors purchasing 4,443 put contracts—about 71% above typical volume—signaling increased hedging or bearish positioning ahead of the report, but not necessarily confirming a change in fundamentals.
• Neutral Sentiment: Institutional positioning was mixed in the latest quarter: 851 investors added shares while 853 reduced holdings. Analyst targets remain varied, with a reported median of $96, suggesting limited upside relative to recent trading levels.
• Negative Sentiment: Investors remain concerned about raw-material and packaging inflation, tariff effects, intense category competition and pressure on consumer spending. Management has also warned that volatile market conditions could persist through the rest of 2026. Colgate-Palmolive defensive rally and earnings risks
• Negative Sentiment: Insiders have reported five open-market sales and no purchases over the past six months, including substantial sales by CEO Noel Wallace. While insider transactions can reflect personal financial decisions, the lack of buying may weigh on sentiment.

Analysts Set New Price Targets

CL has been the subject of several research analyst reports. Citigroup upped their price target on shares of Colgate-Palmolive from $105.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, July 14th. Barclays raised their price target on shares of Colgate-Palmolive from $80.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 21st. Raymond James Financial lifted their price objective on Colgate-Palmolive from $100.00 to $102.00 and gave the stock an "outperform" rating in a report on Monday, August 3rd. Morgan Stanley reiterated an "overweight" rating and set a $104.00 price objective (up from $100.00) on shares of Colgate-Palmolive in a research note on Monday, August 3rd. Finally, Bank of America reduced their target price on Colgate-Palmolive from $102.00 to $100.00 and set a "buy" rating for the company in a report on Friday, October 9th. Thirteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $98.00.

About Colgate-Palmolive

Colgate-Palmolive Company NYSE: CL is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill's Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill's Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.